Micrus Microcoil System Cashmere-Cerecyte, Model CRC; Cashmere-SR, Model SRC
by Micrus Endovascular Corporation
510(k) K072173
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK072173 | Date5 Oct 2007 | StatusActive |
Recalls
-
- Terminated Z-0845-2011
The firm has received reports of difficulty connecting to the detachment control cable. Loss of the electrical connection will result in failure to detach the coil for deployment inside an aneurysm.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- HCG
- Models / Variants
- Device Class
- Class II
- Regulation
- 21 CFR Part 882.5950
- Advisory Committee
- Neurology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Micrus Microcoil System Cashmere-Cerecyte and Cashmere-SR are neurovascular embolization devices classified under the category of neurovascular embolization coils. These devices are intended for the endovascular treatment of intracranial aneurysms by occluding blood flow within the aneurysmal sac, thereby promoting thrombosis and reducing the risk of rupture. The Cashmere-Cerecyte (Model CRC) and Cashmere-SR (Model SRC) models are specifically engineered for precise deployment in neurovascular procedures.
The system is supplied as a sterile, single-use device intended for use in interventional radiology or neurosurgery settings. It requires professional medical personnel to deploy the coils via microcatheters. The device is not MRI-safe and must be used with compatible imaging equipment. Storage conditions are not detailed in the data but generally require protection from moisture and extreme temperatures. The Micrus Microcoil System holds an FDA 510(k) clearance (K072173) for substantial equivalence to predicate devices, affirming its regulatory compliance.
Micrus Microcoil System Cashmere-Cerecyte, Model CRC; Cashmere-SR, Model SRC
Other devices from Micrus Endovascular Corporation
Questions
AI-generated answers, 1 Oct 2026
What are the Micrus Cashmere-Cerecyte and Cashmere-SR coils designed for?
These coils are designed specifically for endovascular treatment of intracranial aneurysms. They work by occluding blood flow within the aneurysm sac, encouraging thrombosis and reducing the risk of rupture. The precise engineering of the Cashmere-Cerecyte (Model CRC) and Cashmere-SR (Model SRC) models ensures accurate deployment during neurovascular procedures.
How are the Micrus Microcoil System Cashmere-Cerecyte and Cashmere-SR supplied?
The system is supplied as a sterile, single-use device. It is intended for professional medical personnel to deploy via microcatheters in interventional radiology or neurosurgery settings. Each coil is packaged individually to maintain sterility until use.
Are these coils MRI-safe?
No, the Micrus Microcoil System Cashmere-Cerecyte and Cashmere-SR coils are not MRI-safe. They must be used with compatible imaging equipment to avoid interference or safety risks during procedures.
What storage conditions should be followed for these coils?
While specific storage instructions are not detailed in the provided data, neurovascular embolization coils generally require protection from moisture and extreme temperatures. Store in a dry, sealed environment away from direct sunlight or heat sources to preserve sterility and integrity.
What regulatory clearance does the Micrus Microcoil System hold?
The device holds an FDA 510(k) clearance (K072173) under substantial equivalence to predicate devices. This clearance confirms regulatory compliance for use in the United States as a neurovascular embolization coil for intracranial aneurysm treatment.